-+ 0.00%
-+ 0.00%
-+ 0.00%

NUVATION BIO - REPORTS 52% CONFIRMED OBJECTIVE RESPONSE RATE IN PHASE 2 SAFUSIDENIB STUDY

Reuters·07/20/2026 12:00:28

Please log in to view news